Maestro inhibitors are a class of chemical agents specifically designed to target the Maestro (MROH) family of proteins, which are involved in a variety of cellular processes due to their regulatory functions. The Maestro family is characterized by the presence of the highly conserved Maestro domain, which is thought to play a role in lipid metabolism and is implicated in the regulation of cellular homeostasis. Inhibitors of Maestro proteins work by disrupting the normal function of these proteins, potentially affecting the pathways in which they are involved. The exact mechanism of action of these inhibitors can vary; some might directly block the active site or the lipid-binding domains of the proteins, while others may indirectly affect the function by altering the protein's conformation or by interfering with its interaction with other cellular components.
The development and identification of Maestro inhibitors is a complex process that typically starts with the screening of compound libraries to find molecules that can bind to the Maestro proteins and inhibit their function. High-throughput screening techniques are often utilized to quickly assess the ability of thousands of compounds to interact with the target proteins. Once candidate inhibitors are identified, they are further tested in a series of biochemical assays to confirm their inhibitory activity and to evaluate their specificity and selectivity for the Maestro proteins, as off-target effects can lead to undesired consequences. To achieve a high level of specificity, it is essential to understand the structural details of the Maestro proteins, which can be accomplished through advanced structural biology techniques such as X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy. These techniques allow scientists to determine the three-dimensional structure of the Maestro proteins, both in their native state and in complex with inhibitors, revealing critical insights into the molecular interactions that underpin the inhibitory effect.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that suppresses phosphoinositide 3-kinase pathway. If Maestro interacts or is influenced by PI3K activity, its modulation could be achieved through this compound. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that acts on the pathway's kinases. Maestro's activity could be indirectly impacted if it's associated with PI3K. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor. Since JNK is involved in various signaling pathways, its inhibition can result in indirect modulation of Maestro if associated. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, a key player in the MAPK signaling pathway. If Maestro has interactions within this pathway, its function might be indirectly influenced by this compound. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor. It inhibits the mammalian target of rapamycin which could modulate Maestro if there's any cross-talk or downstream effect. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that halts the MAPK/ERK signaling. Maestro, if associated with MAPK, can be indirectly influenced by this compound. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibitor of NF-κB activation. NF-κB plays a pivotal role in inflammation, growth, and survival. If Maestro is in any way linked, its function could be modulated by this inhibitor. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Rho-associated protein kinase (ROCK) inhibitor. If Maestro has any interplay with Rho/ROCK signaling, its function might be impacted by this compound. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
FGFR1 inhibitor. It inhibits fibroblast growth factor receptor 1, which, if having any interaction with Maestro, could modulate its activity. | ||||||
ZM 336372 | 208260-29-1 | sc-202857 | 1 mg | $47.00 | 2 | |
RAF kinase inhibitor, playing a role in the MAPK pathway. If Maestro interacts within this pathway, its function could be altered by this compound. | ||||||